{"id":{"repo_id":"birmingham","oai_identifier":"oai:etheses.bham.ac.uk:3255"},"canonical_url":"https://search.ndltd.org/etd/birmingham/oai:etheses.bham.ac.uk:3255","repository":{"repo_id":"birmingham","name":"University of Birmingham","base_url":"https://etheses.bham.ac.uk/cgi/oai2"},"display":{"title":"Improving the clinical effectiveness of physiotherapy in Parkinson’s disease","abstract":"Parkinson’s disease (PD) is a chronic progressive neurodegenerative condition experienced by 120,000 people in the UK and costing £3.3 billion per annum. Treatment for PD predominantly centres on pharmacological therapy, but patients still experience functional deterioration which has led to a multidisciplinary approach to care. Physiotherapy for PD aims to address impairments in function and activity, but the evidence base is still incomplete. This thesis identifies current attitudes and practices and describes the influence of research. The first two studies utilise a modified Delphi survey technique and questionnaire to assess current and perceived best practice and outcome measurement for physiotherapy in PD. Study One revealed that therapy is predominantly delivered in a patient’s home, with the majority of referrals coming from a PD Nurse. Study Two highlighted the support for outcome measures, and a discrepancy between expert generated guidelines and perceived achievable best practice by physiotherapists. Study Three was a randomised controlled trial of supported community exercise. The feasibility and acceptability of the intervention was supported, particularly in its high uptake. Co-operation between researchers and physiotherapists is required to enhance the delivery of best practice. Furthermore, continued methodologically-sound research is needed to underpin physiotherapy for PD.","abstract_html":"Parkinson’s disease (PD) is a chronic progressive neurodegenerative condition experienced by 120,000 people in the UK and costing £3.3 billion per annum. Treatment for PD predominantly centres on pharmacological therapy, but patients still experience functional deterioration which has led to a multidisciplinary approach to care. Physiotherapy for PD aims to address impairments in function and activity, but the evidence base is still incomplete. This thesis identifies current attitudes and practices and describes the influence of research. The first two studies utilise a modified Delphi survey technique and questionnaire to assess current and perceived best practice and outcome measurement for physiotherapy in PD. Study One revealed that therapy is predominantly delivered in a patient’s home, with the majority of referrals coming from a PD Nurse. Study Two highlighted the support for outcome measures, and a discrepancy between expert generated guidelines and perceived achievable best practice by physiotherapists. Study Three was a randomised controlled trial of supported community exercise. The feasibility and acceptability of the intervention was supported, particularly in its high uptake. Co-operation between researchers and physiotherapists is required to enhance the delivery of best practice. Furthermore, continued methodologically-sound research is needed to underpin physiotherapy for PD.","abstract_has_math":false,"creators":["Meek, Charmaine Elise"],"institution":"University of Birmingham","degree_name":"m_ph","degree_level":"m_ph","degree_discipline":null,"degree_department":null,"school":null,"contributors":[],"advisors":[],"committee_chairs":[],"committee_members":[],"year":2012,"date_issued":"2012-07","date_published":"2012-07","updated_at":"2026-11-19T09:27:05Z","subjects":["QP Physiology","RC0321 Neuroscience. Biological psychiatry. Neuropsychiatry","RM Therapeutics. Pharmacology"],"languages":["eng"],"rights":[],"rights_urls":[],"identifier_entries":[],"person_identifier_entries":[]},"links":{"outbound_url":null,"outbound_label":null,"outbound_source":null,"record_url":null,"record_label":null,"record_kind":null,"record_source":null,"download_url":"http://etheses.bham.ac.uk//id/eprint/3255/1/Meek12MPhil.pdf","download_label":"Download PDF","download_source":"dc:identifier.uri","access_status":null,"embargo_until":null,"access_note":null},"source_record":{"url":"https://etheses.bham.ac.uk/cgi/oai2?verb=GetRecord&metadataPrefix=uketd_dc&identifier=oai%3Aetheses.bham.ac.uk%3A3255","prefix":"uketd_dc"},"metadata_groups":[{"id":"people","label":"People","entries":[{"key":"dc:contributor.sponsor","label":"Sponsor","values":["other"]},{"key":"dc:creator","label":"Author","values":["Meek, Charmaine Elise"]}]},{"id":"academic_context","label":"Academic Context","entries":[{"key":"dc:date","label":"Dc Date","values":["2012-07"]},{"key":"dc:date.issued","label":"Date","values":["2012-07"]},{"key":"dc:publisher.department","label":"Dc Publisher Department","values":["College of Medical & Dental Sciences","School of Health and Population Sciences, Primary Care Clinical Sciences"]},{"key":"dc:publisher.institution","label":"Dc Publisher Institution","values":["University of Birmingham"]},{"key":"dc:relation.isreferencedby","label":"Dc Relation Isreferencedby","values":["http://etheses.bham.ac.uk//id/eprint/3255/"]},{"key":"dc:type","label":"Dc Type","values":["Thesis"]},{"key":"dc:type.qualificationlevel","label":"Dc Type Qualificationlevel","values":["m_ph"]},{"key":"dc:type.qualificationname","label":"Dc Type Qualificationname","values":["m_ph"]}]},{"id":"subjects_keywords","label":"Subjects and Keywords","entries":[{"key":"dc:subject","label":"Dc Subject","values":["QP Physiology","RC0321 Neuroscience. Biological psychiatry. Neuropsychiatry","RM Therapeutics. Pharmacology"]}]},{"id":"language_rights","label":"Language and Rights","entries":[{"key":"dc:language.dcterms_iso639_2","label":"Language (ISO 639-2)","values":["eng"]}]},{"id":"identifiers","label":"Identifiers","entries":[{"key":"dc:identifier.uri","label":"Identifier URI","values":["http://etheses.bham.ac.uk//id/eprint/3255/1/Meek12MPhil.pdf","http://etheses.bham.ac.uk//id/eprint/3255/2/Decl_IS_Meek12MPhil.pdf"]}]},{"id":"additional","label":"Additional Metadata","entries":[{"key":"dc:description.abstract","label":"Abstract","values":["Parkinson’s disease (PD) is a chronic progressive neurodegenerative condition experienced by 120,000 people in the UK and costing £3.3 billion per annum. Treatment for PD predominantly centres on pharmacological therapy, but patients still experience functional deterioration which has led to a multidisciplinary approach to care. Physiotherapy for PD aims to address impairments in function and activity, but the evidence base is still incomplete. This thesis identifies current attitudes and practices and describes the influence of research. The first two studies utilise a modified Delphi survey technique and questionnaire to assess current and perceived best practice and outcome measurement for physiotherapy in PD. Study One revealed that therapy is predominantly delivered in a patient’s home, with the majority of referrals coming from a PD Nurse. Study Two highlighted the support for outcome measures, and a discrepancy between expert generated guidelines and perceived achievable best practice by physiotherapists. Study Three was a randomised controlled trial of supported community exercise. The feasibility and acceptability of the intervention was supported, particularly in its high uptake. Co-operation between researchers and physiotherapists is required to enhance the delivery of best practice. Furthermore, continued methodologically-sound research is needed to underpin physiotherapy for PD."]},{"key":"dc:format","label":"Dc Format","values":["application/pdf"]},{"key":"dcterms:accessrights","label":"Dcterms Accessrights","values":["public","staffonly"]},{"key":"dc:title","label":"Title","values":["Improving the clinical effectiveness of physiotherapy in Parkinson’s disease"]}]}],"canonical_facts":{"dc:contributor.sponsor":["other"],"dc:creator":["Meek, Charmaine Elise"],"dc:date":["2012-07"],"dc:date.issued":["2012-07"],"dc:description.abstract":["Parkinson’s disease (PD) is a chronic progressive neurodegenerative condition experienced by 120,000 people in the UK and costing £3.3 billion per annum. Treatment for PD predominantly centres on pharmacological therapy, but patients still experience functional deterioration which has led to a multidisciplinary approach to care. Physiotherapy for PD aims to address impairments in function and activity, but the evidence base is still incomplete. This thesis identifies current attitudes and practices and describes the influence of research. The first two studies utilise a modified Delphi survey technique and questionnaire to assess current and perceived best practice and outcome measurement for physiotherapy in PD. Study One revealed that therapy is predominantly delivered in a patient’s home, with the majority of referrals coming from a PD Nurse. Study Two highlighted the support for outcome measures, and a discrepancy between expert generated guidelines and perceived achievable best practice by physiotherapists. Study Three was a randomised controlled trial of supported community exercise. The feasibility and acceptability of the intervention was supported, particularly in its high uptake. Co-operation between researchers and physiotherapists is required to enhance the delivery of best practice. Furthermore, continued methodologically-sound research is needed to underpin physiotherapy for PD."],"dc:format":["application/pdf"],"dc:identifier.uri":["http://etheses.bham.ac.uk//id/eprint/3255/1/Meek12MPhil.pdf","http://etheses.bham.ac.uk//id/eprint/3255/2/Decl_IS_Meek12MPhil.pdf"],"dc:language.dcterms_iso639_2":["eng"],"dc:publisher.department":["College of Medical & Dental Sciences","School of Health and Population Sciences, Primary Care Clinical Sciences"],"dc:publisher.institution":["University of Birmingham"],"dc:relation.isreferencedby":["http://etheses.bham.ac.uk//id/eprint/3255/"],"dc:subject":["QP Physiology","RC0321 Neuroscience. Biological psychiatry. Neuropsychiatry","RM Therapeutics. Pharmacology"],"dcterms:accessrights":["public","staffonly"],"dc:title":["Improving the clinical effectiveness of physiotherapy in Parkinson’s disease"],"dc:type":["Thesis"],"dc:type.qualificationlevel":["m_ph"],"dc:type.qualificationname":["m_ph"]},"updated_at":"2026-11-19T09:27:05Z"}